April 13, 2022
Evusheld Authorized: New COVID-19 Treatment
The FDA issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld™. Evusheld is a new COVID-19 treatment designed to prevent COVID-19 infection in vulnerable and immunocompromised individuals who may not have an adequate immune response to COVID-19 vaccination. In immunocompromised patients, a vaccination may not generate enough immunity so they are still able to have a severe infection. Evusheld gives...